share_log

Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.

Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals

Olema Pharmaceuticals | SC 13G:超过5%持股股东披露文件
SEC announcement ·  03/22 16:36
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息